Spatiotemporal trends and prognosis of end-stage renal disease patients with biopsy-proven immunoglobulin A nephropathy in France from 2010 to 2014

BACKGROUND: Although end-stage renal disease (ESRD) is frequently used as an outcome marker for primary immunoglobulin A nephropathy (IgAN), the clinical course after reaching ESRD is not well documented. This study examined patients’ characteristics and survival in ESRD-related biopsy-proven IgAN i...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Thomas, Jantzen, Rodolphe, Cambier, Alexandra, Jamme, Matthieu, Couchoud, Cecile, Brunet, Philippe, Gentile, Stéphanie, Rondeau, Eric, Mesnard, Laurent, Lapidus, Nathanael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986328/
https://www.ncbi.nlm.nih.gov/pubmed/33777373
http://dx.doi.org/10.1093/ckj/sfaa029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986328/
https://www.ncbi.nlm.nih.gov/pubmed/33777373
http://dx.doi.org/10.1093/ckj/sfaa029

Ejemplares similares